mRNA Beyond COVID: The 2026 Oncology Supply Chain Playbook
Analysts forecast oncology mRNA will be a multi-billion-dollar market by 2030. The winners won’t just have the best science — they’ll have supply chains that regulators, clinicians, and payers trust.